- Home
- CPBI vs PYXS Comparison
CPBI vs PYXS Comparison
Compare CPBI & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- PYXS
- Stock Information
- Founded
- CPBI 2023
- PYXS 2018
- Country
- CPBI United States
- PYXS United States
- Employees
- CPBI N/A
- PYXS N/A
- Industry
- CPBI
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- PYXS Health Care
- Exchange
- CPBI Nasdaq
- PYXS Nasdaq
- Market Cap
- CPBI 67.1M
- PYXS 79.4M
- IPO Year
- CPBI N/A
- PYXS 2021
- Fundamental
- Price
- CPBI $16.03
- PYXS $3.40
- Analyst Decision
- CPBI
- PYXS Strong Buy
- Analyst Count
- CPBI 0
- PYXS 5
- Target Price
- CPBI N/A
- PYXS $7.75
- AVG Volume (30 Days)
- CPBI 6.5K
- PYXS 877.2K
- Earning Date
- CPBI 01-01-0001
- PYXS 11-11-2025
- Dividend Yield
- CPBI N/A
- PYXS N/A
- EPS Growth
- CPBI 0.69
- PYXS N/A
- EPS
- CPBI 0.98
- PYXS N/A
- Revenue
- CPBI $19,464,000.00
- PYXS $2,820,000.00
- Revenue This Year
- CPBI N/A
- PYXS N/A
- Revenue Next Year
- CPBI N/A
- PYXS N/A
- P/E Ratio
- CPBI $16.55
- PYXS N/A
- Revenue Growth
- CPBI 9.30
- PYXS N/A
- 52 Week Low
- CPBI $13.00
- PYXS $0.83
- 52 Week High
- CPBI $16.71
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- CPBI 51.15
- PYXS 60.58
- Support Level
- CPBI $15.96
- PYXS $3.17
- Resistance Level
- CPBI $16.27
- PYXS $3.75
- Average True Range (ATR)
- CPBI 0.08
- PYXS 0.37
- MACD
- CPBI -0.05
- PYXS -0.05
- Stochastic Oscillator
- CPBI 27.27
- PYXS 50.25
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.